Jiading Industrial Zone Medical & Health Industry Government-Enterprise Closed-Door Exchange Meeting Invitation

The healthcare and biomedical industries represent key strategic high grounds in the new round of technological revolution and industrial transformation, as well as critical sectors for accelerating the cultivation and development of new quality productive forces. In recent years, Shanghai has actively deepened pilot reforms in review and approval processes, systematically advancing the innovative R&D and market application of medical devices, and striving to build a world-class biomedical industry cluster. In 2024, Shanghai saw 10 Class III innovative medical devices approved for market launch, ranking first nationwide.

Jiading, located at the northwestern gateway of Shanghai, serves as a primary hub for high-end manufacturing in the city and a key carrier area for its science and technology innovation center. It is also an important comprehensive node city within the Yangtze River Delta along the Shanghai-Nanjing development axis. As a focal point in Shanghai’s biomedical industry layout, Jiading proactively integrates into the city’s “1+5+X” biomedical industrial framework. Leveraging major hospitals, enterprises, research institutes, and universities—represented by Ruijin Hospital and United Imaging Healthcare—it deepens industry-medical collaboration and coordinated innovation. Jiading is accelerating the development of a hundred-billion-yuan industrial cluster focused on high-performance medical equipment and precision medicine, facilitating the incubation and aggregation of high-caliber biomedical device projects and leading enterprises, thereby significantly promoting the high-quality development of Shanghai’s high-end medical industry.

As a pioneer and leader in the development of the biopharmaceutical industry in Jiading District, Jiading Industrial Zone has been deeply engaged in this sector for over a decade. By deepening the development model of “industry chain leaders + specialized parks + professional teams,” it has focused on building the Shanghai High-End Medical Equipment Industrial Park. The zone has gathered one national-level biopharmaceutical technology business incubator and 20 public technical service platforms, and established a workstation for guidance services on biopharmaceutical product registration. These efforts have accelerated the supply of technological innovations and the conversion of R&D achievements, attracting 332 biopharmaceutical-related enterprises to settle in the zone. In 2024, the total output of the biopharmaceutical industry in Jiading Industrial Zone reached RMB 18.95 billion, an year-on-year increase of 11.9%, accounting for 51.8% of the district’s total. To better promote the clustered development of the industrial chain, Jiading Industrial Zone took the lead in establishing the Jiading District Medical Health Industry Chain Alliance. This alliance builds a collaborative exchange and cooperation platform involving government, industry, academia, research institutions, medical facilities, and capital, continuously helping enterprises in the medical health sector expand their markets, seek talent, and better integrate into the industrial chain, thereby providing substantial support for their development in Jiading.

In this context,Guided by the Shanghai Jiading District Science and Technology Commission and the Shanghai Jiading District Investment Promotion Service Center, hosted by the Shanghai Jiading Industrial Zone Management Committee and Shanghai Jiading Industrial Zone Development (Group) Co., Ltd., organized by the Shanghai Jiading District Economic Development Service Co., Ltd. and Shanghai Jiabei Biomedical Technology Development Co., Ltd., and co-organized by VCBeat, the “Medical-Enterprise Synergy · ‘Jia’ Speed Joint Expansion—Shanghai Jiading Industrial Zone Medical and Health Industry Government-Enterprise Closed-Door Exchange Meeting” will be held in Nanshan District, Shenzhen on March 27 (Thursday)!

This conference will bring together high-quality enterprises from the healthcare sector in the Greater Bay Area, covering specialized fields such as implantable and interventional medical devices, high-value medical consumables, and in vitro diagnostics. It will provide an in-depth, multi-perspective analysis of industry development trends and explore new pathways for industrial growth. Meanwhile, the event will comprehensively showcase Jiading District’s overall strength in healthcare industry development and its targeted support policies, fully highlighting the business advantages of Jiading Industrial Zone in the healthcare sector. By strengthening linkages between government and enterprises, the conference aims to foster mutual benefits and achieve win-win outcomes.

● Conference Information:Thursday, March 27, 14:00-19:30

● Venue:Nanshan District, Shenzhen

● Guiding Organizations:Shanghai Jiading District Science and Technology Commission, Shanghai Jiading District Investment Promotion Service Center

● Organizer:Shanghai Jiading Industrial Zone Management Committee, Shanghai Jiading Industrial Zone Development (Group) Co., Ltd.

● Organizer:Shanghai Jiading District Economic Development Service Co., Ltd., Shanghai Jiabei Biomedical Technology Development Co., Ltd.

● Co-organizers:VCBeat

This event adopts an invitation-only system.Attendance is limited to pharmaceutical and healthcare companies with preliminary interest in collaborating with the Shanghai High-End Medical Equipment Industrial Park., for more information, scan the QR code to add our assistant for consultation.

Shanghai Jiading Industrial Zone, established in October 1992, is one of the first municipal-level industrial parks approved by the Shanghai Municipal People’s Government and has been consecutively awarded the title of “Shanghai Brand Park” for many years. Covering a total area of 78 square kilometers, the zone is located in northwest Shanghai. It lies along the Shanghai-Nanjing development axis and at the heart of the Yangtze River Delta’s 16 economically developed cities, serving as a major transportation hub with extensive connectivity across Jiangsu, Zhejiang, and Shanghai. Over the past three decades, Jiading Industrial Zone has firmly seized development opportunities, pursued innovation and transformation, and strived to catch up and surpass competitors. Since the turn of the new century, it has maintained an average annual growth rate of approximately 10%. Currently, the total gross industrial output value of enterprises above designated size has exceeded RMB 130 billion, while the operating revenue of service enterprises above designated size has reached nearly RMB 27 billion. The total merchandise sales volume and total retail sales of consumer goods have attained RMB 360 billion and RMB 110 billion, respectively. These key economic indicators rank among the top of all major industrial zones in Shanghai. The industrial zone has attracted more than 2,000 corporate entities from over 40 countries and regions, including more than 50 Fortune Global 500 companies and renowned domestic and international enterprises. This has fostered an industrial pattern and ecosystem characterized by “leadership-driven development, cluster-based growth, differentiated competition, and mutual progress.”

Shanghai High-End Medical Equipment Industrial Park, established in 2023, is managed for investment promotion and operations by Shanghai Jiabei Biopharmaceutical Technology Development Co., Ltd. With a gross floor area of 110,000 square meters, the park serves as an investment promotion and service platform for the biopharmaceutical specialty industry within the Shanghai Jiading Industrial Zone. Closely aligned with Jiading District’s goal of building a RMB 100-billion-level industry cluster focused on high-performance medical devices and precision medicine, and leveraging the development and construction of the “United Imaging Town” in the Shanghai Jiading Industrial Zone, the park prioritizes sectors including medical imaging equipment, life science instruments, implantable and interventional devices, biopharmaceutical CROs, and in vitro diagnostics. By fully integrating resources from government, industry, academia, research institutions, and healthcare providers to deeply empower biopharmaceutical enterprises, the park is committed to establishing itself as a premier hub for the R&D, manufacturing, and application of high-end medical equipment in northern Shanghai.Investment Promotion Hotline: 021-59961271